 

Active Ingredient: Acetaminophen; Hydrocodone bitartrate 

 

Dosage Form; Route: Tablet; oral 

 

Recommended Studies: 

 

Acetaminophen; Hydrocodone Bitartrate Tablets are a DESI1 effective drug for which there are no 
known or suspected bioequivalence problems and, as such, this product is rated “AA” in the 
FDA/CDER’s Approved Drug Products with Therapeutic Equivalence Evaluations (“Orange Book”). 

1 Drug Efficacy Study Implementation 

 

 

Analytes to measure (in appropriate biological fluid): Not applicable 

 

Bioequivalence based on (90% CI): Not applicable 

 

Waiver request of in vivo testing: 325 mg/2.5 mg, 325 mg/5 mg, 325 mg/7.5 mg, 325 mg/10 mg, 
300 mg/5 mg, 300 mg/7.5 mg and 300 mg/10 mg pursuant to 21 CFR 320.22 (c) provided that the in 
vitro dissolution profiles of the proposed product are comparable to those of the reference product 

 

Dissolution test method and sampling times: The dissolution information for this drug 
product can be found on the FDA-Recommended Dissolution Methods website, available to the 
public at the following location: http://www.accessdata.fda.gov/scripts/cder/dissolution/. 
Conduct comparative dissolution testing on 12 dosage units each of all strengths of the test and 
reference products. Specifications will be determined upon review of the abbreviated new drug 
application (ANDA). 

 

 

 

 

 


